The twice-yearly injection offers near-100% protection against HIV — and a life-changing alternative to taking daily pills. Generic versions are expected at around $40 per person per year by 2027, when the drug will also become available in 120 low- and middle-income countries.

South Africa launches accessible and effective HIV prevention jab
FRANCE 24